AP261A - Phenylacetamides derivatives. - Google Patents

Phenylacetamides derivatives. Download PDF

Info

Publication number
AP261A
AP261A APAP/P/1991/000306A AP9100306A AP261A AP 261 A AP261 A AP 261A AP 9100306 A AP9100306 A AP 9100306A AP 261 A AP261 A AP 261A
Authority
AP
ARIPO
Prior art keywords
acetyl
methoxy
hydrogen
formula
vith
Prior art date
Application number
APAP/P/1991/000306A
Other languages
English (en)
Other versions
AP9100306A0 (en
Inventor
David Robert Brittain
Steven Paul Brown
Anthon Loren Cooper
Jethro Lawrence Longridge
Jeffrey James Morris
John Preston
Linda Slater
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10680064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP261(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of AP9100306A0 publication Critical patent/AP9100306A0/xx
Application granted granted Critical
Publication of AP261A publication Critical patent/AP261A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • C07C317/40—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/04—Sulfinic acids; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/1991/000306A 1990-08-02 1991-07-22 Phenylacetamides derivatives. AP261A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016978A GB9016978D0 (en) 1990-08-02 1990-08-02 Acetamide derivatives

Publications (2)

Publication Number Publication Date
AP9100306A0 AP9100306A0 (en) 1991-07-31
AP261A true AP261A (en) 1993-06-03

Family

ID=10680064

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000306A AP261A (en) 1990-08-02 1991-07-22 Phenylacetamides derivatives.

Country Status (33)

Country Link
US (2) US5270342A (ja)
EP (1) EP0469887B1 (ja)
JP (1) JP2930452B2 (ja)
KR (1) KR920004342A (ja)
CN (1) CN1036389C (ja)
AP (1) AP261A (ja)
AT (1) ATE115560T1 (ja)
AU (1) AU646273B2 (ja)
BG (1) BG60316B2 (ja)
CA (1) CA2048325A1 (ja)
CZ (1) CZ280642B6 (ja)
DE (1) DE69105856T2 (ja)
DK (1) DK0469887T3 (ja)
ES (1) ES2067874T3 (ja)
FI (1) FI913706A (ja)
GB (2) GB9016978D0 (ja)
HK (1) HK1000965A1 (ja)
HR (1) HRP931326B1 (ja)
HU (2) HU210057B (ja)
IE (1) IE65870B1 (ja)
IL (1) IL98908A (ja)
JO (1) JO1696B1 (ja)
MY (1) MY109594A (ja)
NO (1) NO175528C (ja)
NZ (1) NZ239124A (ja)
PH (1) PH31572A (ja)
PL (2) PL166392B1 (ja)
PT (1) PT98529B (ja)
RO (1) RO109645B1 (ja)
RU (1) RU2068409C1 (ja)
SI (1) SI9111318A (ja)
YU (1) YU131891A (ja)
ZA (1) ZA915783B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016978D0 (en) * 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
GB9016984D0 (en) * 1990-08-02 1990-09-19 Ici Plc Aniline derivatives
KR0147963B1 (ko) * 1995-01-10 1998-08-17 강박광 엔-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
FR2757509B1 (fr) * 1996-12-23 1999-03-26 Lipha Nouveaux derives de sulfonamides et sulfonylurees, leurs preparations et medicaments les contenant
GEP20022709B (en) * 1997-04-15 2002-06-25 Csir Za Pharmaceutical Compositions Having Appetite Suppressant Activity
GB9714274D0 (en) 1997-07-08 1997-09-10 Zeneca Ltd Pharmaceutical composition
US6803357B1 (en) 1998-02-02 2004-10-12 New England Medical Center Hospitals, Inc. Method of regulating glucose metabolism, and reagents related thereto
GB2396815B (en) * 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
AU2002215160A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
DK1877370T3 (da) * 2005-04-28 2009-05-11 Shiratori Pharm Fremgangsmåde til fremstilling af hydrazon-derivater
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2016065B1 (en) * 2005-12-28 2012-09-19 Vertex Pharmaceuticals Incorporated 1-(benzo[d][1,3]dioxol-5-yl)-n-(phenyl)cyclopropane-carboxamide derivatives and related compounds as modulators of atp-binding cassette transporters for the treatment of cystic fibrosis
ATE518544T1 (de) 2007-03-12 2011-08-15 Zadec Aps Rotbusch-extrakt gegen diabetes
CA2685202C (en) 2007-03-23 2017-11-28 The Board Of Regents Of The University Of Texas System Methods for treating allergic asthma
FR2914188B1 (fr) * 2007-03-28 2012-06-22 Trophos Nouvelle composition a base d'oxime de cholest-4-en-3-one
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
US8785483B2 (en) 2010-12-23 2014-07-22 The Board Of Regents Of The University Of Texas System Methods for treating COPD

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169887A1 (en) * 1984-02-01 1986-02-05 William C Hulette CLINICAL ANALYSIS SYSTEM AND METHOD.
EP0304190A1 (en) * 1987-08-06 1989-02-22 Imperial Chemical Industries Plc (Arylsulphonyl)nitromethanes, process for their preparation and use in pharmaceutical compositions
WO1990008761A1 (en) * 1989-02-06 1990-08-09 Imperial Chemical Industries Plc Phenylsulphone derivatives
GB2247678A (en) * 1990-08-02 1992-03-11 Ici Plc Acetamide derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1229653A (ja) * 1968-03-14 1971-04-28
US3882247A (en) * 1972-04-21 1975-05-06 Du Pont Fungicidal nitro organic sulfur compounds
SU479761A1 (ru) * 1973-07-18 1975-08-05 Институт Органической Химии Им. Н.Д.Зелинского Ан Ссср Способ получени -динитроалкилсульфонов
US4053633A (en) * 1976-06-24 1977-10-11 The Dow Chemical Company Aryl dibromonitromethyl sulfones
US4058633A (en) * 1976-09-15 1977-11-15 Fairmont Foods Company Meat product, and process for preparing same
FR2432316A1 (fr) * 1978-08-02 1980-02-29 Choay Sa Nouveaux medicaments contenant, a titre de substance active, des composes de type benzenesulfone, nouveaux composes de ce type et procede pour leur preparation
US4670470A (en) * 1979-08-15 1987-06-02 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4309554A (en) * 1980-04-28 1982-01-05 The Dow Chemical Company 3-(2-Thiophenesulfonyl)-2-halopropanenitriles
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DE3326635A1 (de) * 1983-07-23 1985-01-31 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von monomethylsubstituierten methylen-verbindungen
DE3768352D1 (de) * 1986-06-30 1991-04-11 Merck & Co Inc Alkansulfonamide als antiglaucoma-mittel.
GB8810203D0 (en) * 1988-04-29 1988-06-02 Ici Plc Heterocyclic compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169887A1 (en) * 1984-02-01 1986-02-05 William C Hulette CLINICAL ANALYSIS SYSTEM AND METHOD.
EP0304190A1 (en) * 1987-08-06 1989-02-22 Imperial Chemical Industries Plc (Arylsulphonyl)nitromethanes, process for their preparation and use in pharmaceutical compositions
WO1990008761A1 (en) * 1989-02-06 1990-08-09 Imperial Chemical Industries Plc Phenylsulphone derivatives
GB2247678A (en) * 1990-08-02 1992-03-11 Ici Plc Acetamide derivatives

Also Published As

Publication number Publication date
SI9111318A (en) 1997-10-31
CN1059517A (zh) 1992-03-18
HK1000965A1 (en) 1998-05-15
ES2067874T3 (es) 1995-04-01
EP0469887B1 (en) 1994-12-14
CS232791A3 (en) 1992-03-18
YU131891A (sh) 1994-06-10
ATE115560T1 (de) 1994-12-15
EP0469887A1 (en) 1992-02-05
CZ280642B6 (cs) 1996-03-13
AP9100306A0 (en) 1991-07-31
NZ239124A (en) 1994-04-27
HU210057B (en) 1995-01-30
DK0469887T3 (da) 1995-04-03
HUT59088A (en) 1992-04-28
AU646273B2 (en) 1994-02-17
FI913706A (fi) 1992-02-03
MY109594A (en) 1997-03-31
DE69105856D1 (de) 1995-01-26
PT98529A (pt) 1992-06-30
JP2930452B2 (ja) 1999-08-03
GB2247678B (en) 1994-07-27
PH31572A (en) 1998-11-03
HRP931326B1 (en) 1998-06-30
IE912529A1 (en) 1992-02-12
CA2048325A1 (en) 1992-02-03
IE65870B1 (en) 1995-11-29
PL166392B1 (pl) 1995-05-31
JPH04234356A (ja) 1992-08-24
HRP931326A2 (en) 1996-04-30
RO109645B1 (ro) 1995-04-28
BG60316B2 (bg) 1994-07-25
PL168026B1 (pl) 1995-12-30
NO913008L (no) 1992-02-03
AU8123391A (en) 1992-02-06
GB9115254D0 (en) 1991-08-28
US5430060A (en) 1995-07-04
IL98908A (en) 1995-03-30
CN1036389C (zh) 1997-11-12
NO175528C (no) 1994-10-26
FI913706A0 (fi) 1991-08-02
PL291312A1 (en) 1992-09-21
PT98529B (pt) 1999-01-29
US5270342A (en) 1993-12-14
IL98908A0 (en) 1992-07-15
DE69105856T2 (de) 1995-05-11
NO175528B (no) 1994-07-18
HU210883A9 (en) 1995-09-28
RU2068409C1 (ru) 1996-10-27
GB2247678A (en) 1992-03-11
JO1696B1 (en) 1992-12-15
KR920004342A (ko) 1992-03-27
NO913008D0 (no) 1991-08-01
ZA915783B (en) 1992-05-27
HU912482D0 (en) 1991-12-30
GB9016978D0 (en) 1990-09-19

Similar Documents

Publication Publication Date Title
AP261A (en) Phenylacetamides derivatives.
EP0469889B1 (en) (p-Carbonylaminophenyl)-sulphonyl-nitromethane derivatives
RU2034834C1 (ru) (4-амино-2,6-диметилфенилсульфонил)нитрометан, (4-ацетамидо-2,6-диметилфенилсульфонил)нитрометан и фармацевтическая композиция, обладающая свойствами ингибитора фермента альдозоредуктазы
US5250570A (en) Amidobenzene derivatives, compositions and use
EP0469888B1 (en) Amidobenzenes
IL98967A (en) History of Inline Process for their preparation and pharmaceutical preparations containing them